EUVIMEDEUVIMED entdecken
Open Access · CC0

Structure-based virtual screening, molecular docking, and MD simulation studies: An in-silico approach for identifying potential MBL inhibitors

Strukturbasierte virtuelle Substanzsuche, Moleküldocking und MD-Simulation: ein in-silico-Ansatz zur Identifikation potenzieller MBL-Inhibitoren

Emira Noumi, Mejdi Snoussi iD, Nouha Bouali, Mamdouh M Alshammari, Hisham N Altayb, Muhammad Afzal, Vincenzo De Feo

PLOS One · 31.07.2025 · 20 (7) · e0324836

DOI: 10.1371/journal.pone.0324836 ↗

Auf einen Blick

In einer in-silico-Studie wurden 4.561 Naturstoffverbindungen gegen NDM-1 geprüft. S904-0022 zeigte die stabilste Bindung und die günstigste Bindungsfreie Energie.

Fragestellung

Welche Naturstoffverbindungen könnten als Inhibitoren von NDM-1 und anderen MBLs geeignet sein?

Methode

4.561 Naturstoffverbindungen wurden mit einem ML-basierten QSAR-Modell gescreent; danach Docking, Tanimoto-Clustering und 300 ns MD-Simulation.

Ergebnisse

Die drei vielversprechendsten Verbindungen waren S721-1034, S904-0022 und N118-0137. S904-0022 zeigte konstante RMSD-Werte und eine Bindungsfreie Energie von −35,77 kcal/mol; Kontrolle: −18,90 kcal/mol.

Schlussfolgerung der Autor:innen

Die Autor:innen schlussfolgern, dass S904-0022 ein erhebliches therapeutisches Potenzial als potenzieller NDM-1-Inhibitor hat und weiter experimentell geprüft werden sollte.

Kernaussagen

  • 4.561 Verbindungen wurden in silico gegen NDM-1 gescreent
  • S904-0022 zeigte die stabilste Interaktion in der MD-Simulation
  • Bindungsfreie Energie: −35,77 kcal/mol vs. −18,90 kcal/mol

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 31.07.2025. Verfasst von Emira Noumi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, University of Ha'il, Hail, Saudi Arabia. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Molecular Dynamics Simulation, beta-Lactamases, beta-Lactamase Inhibitors. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: University of Ha’il.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global rise of antibiotic-resistant infections has been driven in part by the spread of bacteria producing metallo-β-lactamase (MBL), particularly New Delhi metallo-β-lactamase-1 (NDM-1). Currently, there are no clinically approved inhibitors targeting NDM-1 or other MBLs, highlighting the urgent need for novel therapeutic agents. This study addresses this gap by identifying potential NDM-1 inhibitors through a comprehensive in silico workflow. A total of 4,561 natural product compounds were screened using a machine learning (ML)-based quantitative structure–activity relationship (QSAR) model. Molecular docking was then performed to prioritize hits, followed by Tanimoto similarity-based clustering to identify representative compounds. The three most promising compounds identified were S721-1034 , S904-0022, and N118-0137 . 300 ns molecular dynamics (MD) simulation was used to examine binding interactions and stability of a control molecule (meropenem (0RV)) and the three selected compounds ( S721-1034 , S904-0022, and N118-0137 ) with the target protein. Among the three compounds evaluated, S904-0022 demonstrated consistent root mean square deviation (RMSD) values throughout the molecular dynamics (MD) simulation compared to the other two ligands. Additionally, S904-0022 exhibited considerable affinity with key residues, including Gln123, His250, Trp93, and Val73, indicating robust interactions with NDM-1. The strength of this interaction was further validated by a significantly favorable binding free energy of −35.77 kcal/mol, markedly better than the control compound (−18.90 kcal/mol). The strength of this interaction was further validated by a significantly favorable binding free energy of −35.77 kcal/mol, markedly better than the control compound (−18.90 kcal/mol). The findings of this study provide valuable insights into the molecular interactions and stability of these compounds, which can be used to improve drug development and explore the interactions between proteins and ligands. The study concluded that S904-0022 exhibited substantial therapeutic potential and requires additional experimental exploration as a potential NDM-1 inhibitor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationMolecular Dynamics Simulationbeta-Lactamasesbeta-Lactamase InhibitorsQuantitative Structure-Activity RelationshipDrug Evaluation, Preclinical

Substanzen

beta-Lactamasesbeta-Lactamase Inhibitorsbeta-lactamase NDM-1

Autor:innen und Institutionen

  • Department of Biology, College of Science, University of Ha'il, Hail, Saudi Arabia.
  • Medical and Diagnostic Research Centre, University of Ha'il, Hail, Saudi Arabia.
  • Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Faculty of Medical Laboratory Science, Sudan University of Science and Technology, Khartoum, Sudan.
  • Department of Pharmaceutical Sciences, Batterjee Medical College, Pharmacy Program, Jeddah, Saudi Arabia.
  • Department of Pharmacy, University of Salerno, Salerno, Italy.

ORCID-Profile: Mejdi Snoussi

Förderung

  • University of Ha’il

Zitieren

APA

Noumi, E., Snoussi, M., Bouali, N., Alshammari, M. M., Altayb, H. N., Afzal, M., & De Feo, V. (2025). Structure-based virtual screening, molecular docking, and MD simulation studies: An in-silico approach for identifying potential MBL inhibitors. PLOS One, 20(7), e0324836. https://doi.org/10.1371/journal.pone.0324836

Vancouver

Noumi E, Snoussi M, Bouali N, Alshammari MM, Altayb HN, Afzal M, et al. Structure-based virtual screening, molecular docking, and MD simulation studies: An in-silico approach for identifying potential MBL inhibitors. PLOS One. 2025;20(7):e0324836. doi:10.1371/journal.pone.0324836

BibTeX
@article{Noumi2025,
  author = {Noumi, Emira and Snoussi, Mejdi and Bouali, Nouha and Alshammari, Mamdouh M and Altayb, Hisham N and Afzal, Muhammad and De Feo, Vincenzo},
  title = {Structure-based virtual screening, molecular docking, and MD simulation studies: An in-silico approach for identifying potential MBL inhibitors},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {7},
  pages = {e0324836},
  doi = {10.1371/journal.pone.0324836}
}
Kostenlos starten →